NCT04626700 is a NA clinical trial of iNAP in OSA, sponsored by Chang Gung Memorial Hospital.

Who is sponsoring NCT04626700?

NCT04626700 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT04626700?

Interventions in NCT04626700: iNAP, CPAP.

What condition does NCT04626700 study?

NCT04626700 studies OSA, iNAP, DISE.

Is NCT04626700 still recruiting?

NCT04626700 is currently status unknown. Last updated 12 November 2020.

Last reviewed 2020-11-12 · How we verify

NCT04626700

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison for Oral Negative Pressure Therapy and CPAP for OSA Under Sleep Endoscopy Assistance: A Randomized Controlled Trial

Status unknown NA Last updated 12 November 2020

What this trial tests

NA trial testing iNAP in OSA in 60 participants. Status unknown.

Timeline

14 August 2019

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	14 August 2019
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Taiwan

Drugs / interventions tested

iNAP
CPAP

Conditions studied

OSA — all drugs for OSA →
iNAP — all drugs for iNAP →
DISE — all drugs for DISE →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 18 to 100, any sex, with OSA or iNAP. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is the study entitled "Comparison for oral negative pressure therapy and CPAP for OSA under sleep endoscopy assistance: A randomized controlled trial". CPAP is first line golden standard treatment for Obstructive sleep apnea (OSA). However, the overall CPAP compliance is poor. Recent study reveals that oral negative pressure therapy improves apnea severity in OSA patients with good compliance. However, no study is designed to compare oral negative pressure therapy and CPAP for OSA patients. In addition, the effect of oral negative pressure therapy for hypopharynx is unclear. Therefore, we will perform druginduced sleep endoscopy to evaluate upper airway obstruction of OSA patients before treatment. OSA patients will be assigned into oral negative pressure group or CPAP group for 2 months. Sleepiness, sleep quality, residual apnea severity and compliance will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for OSA

Currently open trials in the same condition.

NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
NCT07060079 — The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease · recruiting
NCT06110962 — Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor · recruiting
NCT06591169 — Lifestyle Changes in PCOS with OSA and NAFLD · NA · recruiting
NCT06091098 — Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA · NA · recruiting

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04626700 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 12 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04626700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing